HOME >> BIOLOGY >> NEWS
Audience pick: Older violin, sweeter music?

lections of Nagyvary's choosing will be played by Regina Buonavenura from Manilla, The Philippines, in honor of Nagyvary's retirement. Nagyvary enlisted Bounavenura, who owns a violin made by him, to play his own 10-year-old violin.

The scientist said he will consider the comparison concert a success if as many as 40 percent pick his violin as the Stradivarius.

Nagyvary, who in the 1980s began using his knowledge of biochemistry to study the intricacies of the famous violins made in the 18th century by Antonio Stradivari, is not one to duck a challenge. Under the sponsorship of the American Chemical Society two years ago, one of his violins was pitted against an average Stradivarius (some 700 still exist) for a comparison test. Critics at that time could not tell the violins apart, Nagyvary said, though some reported they could detect a slight difference. A CD recording of that event is available for $14 by calling 800-523-5184, Nagyvary said.

This comparison concert will be different for several reasons: the ultimate of Stradivari violins - the $4 million Rochester - will go up for the test; the audience will get to decide which sounds better; and, a film crew will get footage for an upcoming film about Antonio Stradivari that will be broadcast around the world.

To prepare for the event, Nagyvary whipped out a new violin in a record six weeks, allowing that 300-year-old maple from the Himalayan mountains in China had been prepared some six months ago. With the violin fully assembled in mid-July, Nagyvary began vibrating the violin - mostly mechanically - to condition it for playing. A violin has to be played in tune -- every position and every note with the scales and ambitious music -- to be balanced, Nagyvary explained.

"I'm even attempting to fake the age so that even if the screen were removed, the audience would not be able to tell the two violins apart," Nagyvary said.

The
'"/>

Contact: Kathleen Phillips
ka-phillips@tamu.edu
979-845-2872
Texas A&M University - Agricultural Communications
26-Aug-2003


Page: 1 2 3

Related biology news :

1. "Health Of Hanford" Conference Gathers Diverse Audience To Review And Discuss Health Issues
2. Older drug could have exciting new role in treating colorectal cancer
3. Older pilots OK to fly, study shows
4. Older adults can exercise just once a week to maintain muscle strength
5. Older fathers more likely to have children with schizophrenia
6. Older fathers substantially raise the risk of having children with schizophrenia
7. Vitamin D Deficiency May Increase Risk Of Hip Fracture In Older Women
8. PSA Levels Mean More Extensive Prostate Disease In Older Men
9. Florida Or Bust? Older Lab Rats Seek Heat To Fight Infection, UD Researchers Report
10. American Heart Association Comment: Sodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons
11. Long-Term Vitamin C Use Cuts Cataract Risk In Older Women

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Audience pick Older violin sweeter music

(Date:10/17/2014)... – Accurate knowledge regarding Ebola is critical and pertinent ... of hazardous global outbreak and epidemic. The Journal, ... a special issue, Ebola Virus and Public Health, to ... knowledge in this critical societal moment. , On ... Ebola for Clinicians . The primer was prepared by ...
(Date:10/17/2014)... This news release is available in German . ... for only a very few drugs. When treating overdoses, doctors ... Treatment is especially difficult if there is a combination of ... is playing and accidentally swallows his grandmother,s pills? ETH professor ... Zurich wanted to find an answer to this question. "The ...
(Date:10/16/2014)... managers have a new synthesis of recent research findings ... forests in the two states. , The Ecology ... and Washington: A Synthesis of the Relevant Biophysical Science ... report published by the U.S. Forest Service,s Pacific Northwest ... from managers for a synthesis of the large body ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
(Date:10/22/2014)... -- Nuvilex, Inc. (OTCQB: NVLX) – According to the ... living with diabetes, with  that number expected to grow ... for diabetes treatments is approximately $500 billion.  ... pancreatic cancer.  Pancreatic cancer is the fourth most common ... the United States , and according to a ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by ... Systems, Table-top Counters) by End-user (Inpatient Pharmacy Automation, ... to 2019” analyzes and studies the major market ... Asia-Pacific, and the Rest of the World (RoW). ... spread through 300 pages and in-depth TOC on ...
(Date:10/20/2014)... PARK, Calif. , Oct. 20, 2014 /PRNewswire/ ... today that the Company has signed a Notice ... of Regenerative Medicine (CIRM), effective October 1, 2014.  ... Clinical Development payments and the release of additional ... million CIRM grant award for clinical development of ...
(Date:10/20/2014)...  GenVec, Inc. (NASDAQ: GNVC ) today announced ... its board of directors effective on October 24, 2014.   Dr. ... as its chairman from June 2006 to November 2013.  During ... Governance and Audit Committees of the board.  ... dedicated service to GenVec, and its stockholders," said Wayne ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4Zola P. Horovitz To Retire From GenVec Board 2
Cached News: